Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 0
---
Filed pursuant to Rule 424(b)(3)

Registration No. 333-286497

PROSPECTUS

<div align='center'>bioAffinity Technologies, Inc.

3,013,951 Shares of Common Stock</div>

This prospectus relates to the resale from time to
time of up to 3,013,951 shares of common stock, par value $0.007 per share (the “Common Stock”), of bioAffinity Technologies,
Inc. by the Selling Stockholders identified in this prospectus (the “Selling Stockholders”), including their pledgees, assignees,
donees, transferees or their respective successors-in-interest consisting of: (i) 2,926,166 shares of Common Stock issuable upon the exercise
of common warrants (the “Inducement Warrants”) to purchase 2,926,166 shares of Common Stock (the “Inducement Warrant
Shares”) issued to certain holders (the “Holders”) of existing warrants in a warrant inducement private placement transaction
(the “Warrant Inducement”) pursuant to the terms of a warrant inducement agreement, dated February 25, 2025 (the “Inducement
Agreement”) between us and the Holders; and (ii) 87,785 shares of Common Stock issuable upon the exercise of warrants (the “Advisor
Warrants”) to purchase 87,785 shares of Common Stock (the “Advisor Warrant Shares”) issued to designees of WallachBeth
Capital LLC (“WallachBeth”) issued as partial compensation for WallachBeth acting as financial advisor in connection with
the Warrant Inducement. The Warrant Inducement closed on February 26, 2025. The Holders and the designees of WallachBeth that received
Advisor Warrants are collectively referred to herein as the “Selling Stockholders.” The Inducement Warrants and the Advisor
Warrants are collectively referred to herein as the “Common Warrants.” The Inducement Warrant Shares and the Advisor Warrant
Shares are collectively referred to herein as the “Common Warrant Shares.”

We are filing this registration statement on Form
S-1, of which this prospectus forms a part, to fulfill our contractual obligations to provide for the registration of the resale of the
Inducement Warrant Shares by the Holders, as well as to provide for the registration of the resale of the Placement Agent Warrant Shares
by the designees